William D. Waddill Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

William D. Waddill is Director of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 47,870 shares of ARWR, which is worth approximately $1.2 Million. The most recent transaction as insider was on Jan 11, 2024, when has been sold 3,934 shares (Common Stock) at a price of $38.2 per share, resulting in proceeds of $150,278. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.9K

0% 3M change

30.02% 12M change

Total Value Held $1.2 Million

William D. Waddill Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 11 2024	SELL Open market or private sale	$150,278 $38.2 p/Share	3,934 Reduced 7.59%	47,870 Common Stock
Dec 15 2023	BUY Grant, award, or other acquisition	$380,819 $25.41 p/Share	14,987 Added 22.44%	51,804 Common Stock
Jan 10 2023	BUY Grant, award, or other acquisition	-	7,867 Added 17.61%	36,817 Common Stock
Jan 09 2023	SELL Open market or private sale	$96,000 $30.0 p/Share	3,200 Reduced 9.95%	28,950 Common Stock
Jan 07 2022	BUY Grant, award, or other acquisition	-	6,400 Added 16.6%	32,150 Common Stock
Jan 03 2022	SELL Open market or private sale	$293,220 $65.16 p/Share	4,500 Reduced 14.88%	25,750 Common Stock
Jan 04 2021	SELL Open market or private sale	$285,300 $76.08 p/Share	3,750 Reduced 11.03%	30,250 Common Stock

Jan 01 2021	BUY Grant, award, or other acquisition	-	9,000 Added 20.93%	34,000 Common Stock
Dec 10 2020	SELL Open market or private sale	$212,400 $70.8 p/Share	3,000 Reduced 10.71%	25,000 Common Stock

Also insider at

PTGX

Protagonist Therapeutics, Inc Healthcare

Director

ANNX

Annexon, Inc. Healthcare

TSBX

Turnstone Biologics Corp.

WDW